News
VVOS
4.650
+4.03%
0.180
Vivos Therapeutics Inc <VVOS.OQ> expected to post a loss of $1.90 a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of $1.90 a share - Earnings Preview. Vivos expected to show a fall in quarterly revenue when it reports results on March 28. The company is expected to report a 13.8% decrease in revenue to $3.406 million.
Reuters · 1d ago
Weekly Report: what happened at VVOS last week (0318-0322)?
Weekly Report · 2d ago
Weekly Report: what happened at VVOS last week (0311-0315)?
Weekly Report · 03/18 12:14
12 Health Care Stocks Moving In Friday's Pre-Market Session
Better Therapeutics (NASDAQ:BTTX) shares increased by 85.4% to $0.06 during Friday's pre-market session. Madrigal Pharmaceuticals shares moved upwards by 22.34%. Akebia Therapeutic and Rallybio both reported better than expected Q4 earnings.
Benzinga · 03/15 13:06
Weekly Report: what happened at VVOS last week (0304-0308)?
Weekly Report · 03/11 12:09
Weekly Report: what happened at VVOS last week (0226-0301)?
Weekly Report · 03/04 12:12
Weekly Report: what happened at VVOS last week (0219-0223)?
Weekly Report · 02/26 12:32
Weekly Report: what happened at VVOS last week (0212-0216)?
Weekly Report · 02/19 12:35
Vivos Therapeutics Secures $8M Through Strategic Equity Deals
TipRanks · 02/15 14:14
Vivos Therapeutics announces exercise of warrants for proceeds of $4M
Healthcare Vivos Therapeutics announces exercise of warrants for proceeds of $4M. VivosTherapeutics says it has entered into an agreement for the immediate exercise of an outstanding stock purchase warrant held by an institutional investor to buy 980.4K shares for gross proceeds.
Seeking Alpha · 02/15 13:17
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Applied Therapeutics (NASDAQ:APLT) stock rose 24.6% to $3.34 during Thursday's pre-market session. American Well (NYSE:AMWL) shares moved upwards by 11.71% during the same session. KalVista Pharma ( NASDAQ:KALV) shares increased by 15.83%. Recursion Pharmaceuticals and Meihua Intl Medical Techs also moved upwards.
Benzinga · 02/15 13:05
Vivos Therapeutics Announces Exercise Of Warrants For ~$4M Aggregate Gross Proceeds
Vivos Therapeutics, Inc. Is a leading medical device and technology company specializing in the development and commercialization of treatments for sleep related breathing disorders. The Company has entered into a definitive agreement for the immediate exercise of an outstanding warrant held by an institutional investor to purchase shares of Vivos common stock for approximately $4.0 million.
Benzinga · 02/15 13:04
Weekly Report: what happened at VVOS last week (0205-0209)?
Weekly Report · 02/12 12:19
Weekly Report: what happened at VVOS last week (0129-0202)?
Weekly Report · 02/05 12:32
CRBP, PXLW and VVOS among mid-day movers
Seeking Alpha · 01/30 16:50
12 Health Care Stocks Moving In Monday's Intraday Session
OneMedNet shares increased by 175.1% to $1.41 during Monday's regular session. NexImmune shares moved upwards by 84.48%. FibroGen shares rose 54.93% during the session. Losers include Panbela Therapeutics and Processa Pharma.
Benzinga · 01/29 17:31
Weekly Report: what happened at VVOS last week (0122-0126)?
Weekly Report · 01/29 12:14
Weekly Report: what happened at VVOS last week (0115-0119)?
Weekly Report · 01/22 12:21
Weekly Report: what happened at VVOS last week (0108-0112)?
Weekly Report · 01/15 12:15
Vivos Therapeutics Inc: Correspondence
Press release · 01/09 02:04
More
Webull provides a variety of real-time VVOS stock news. You can receive the latest news about Vivos Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VVOS
Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a suit of diagnostic and multi-disciplinary treatment modalities for patients with cranial and/or dentofacial abnormalities and an array of medical conditions, including mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company's Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company's program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. The Vivos Method comprises of various products and services, such as Vivos Complete Airway Repositioning and/or Expansion (CARE) oral appliance therapy; VivosGuides; Vivos Versa; POD and Night Block, and VivosMyoCorrect.